SMART: Self-Management of Anticoagulation, a Randomised Trial [ISRCTN19313375]
<p>Abstract</p> <p>Background</p> <p>Oral anticoagulation monitoring has traditionally taken place in secondary care because of the need for a laboratory blood test, the international normalised ratio (INR). The development of reliable near patient testing (NPT) systems...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2003-09-01
|
Series: | BMC Family Practice |
Online Access: | http://www.biomedcentral.com/1471-2296/4/11 |
id |
doaj-5b26bcccec2a4ef19e2b09a8364af4b1 |
---|---|
record_format |
Article |
spelling |
doaj-5b26bcccec2a4ef19e2b09a8364af4b12020-11-25T03:13:15ZengBMCBMC Family Practice1471-22962003-09-01411110.1186/1471-2296-4-11SMART: Self-Management of Anticoagulation, a Randomised Trial [ISRCTN19313375]Murray Ellen TFitzmaurice David AMcCahon DeborahFuller Christopher JHobbs Richard FDAllan Teresa FRaftery James P<p>Abstract</p> <p>Background</p> <p>Oral anticoagulation monitoring has traditionally taken place in secondary care because of the need for a laboratory blood test, the international normalised ratio (INR). The development of reliable near patient testing (NPT) systems for INR estimation has facilitated devolution of testing to primary care. Patient self-management is a logical progression from the primary care model. This study will be the first to randomise non-selected patients in primary care, to either self-management or standard care.</p> <p>Method</p> <p>The study was a multi-centred randomised controlled trial with patients from 49 general practices recruited. Those suitable for inclusion were aged 18 or over, with a long term indication for oral anticoagulation, who had taken warfarin for at least six months. Patients randomised to the intervention arm attended at least two training sessions which were practice-based, 1 week apart. Each patient was assessed on their capability to undertake self management. If considered capable, they were given a near patient INR testing monitor, test strips and quality control material for home testing. Patients managed their own anticoagulation for a period of 12 months and performed their INR test every 2 weeks. Control patients continued with their pre-study care either attending hospital or practice based anticoagulant clinics.</p> <p>Discussion</p> <p>The methodology used in this trial will overcome concerns from previous trials of selection bias and relevance to the UK health service. The study will give a clearer understanding of the benefits of self-management in terms of clinical and cost effectiveness and patient preference.</p> http://www.biomedcentral.com/1471-2296/4/11 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Murray Ellen T Fitzmaurice David A McCahon Deborah Fuller Christopher J Hobbs Richard FD Allan Teresa F Raftery James P |
spellingShingle |
Murray Ellen T Fitzmaurice David A McCahon Deborah Fuller Christopher J Hobbs Richard FD Allan Teresa F Raftery James P SMART: Self-Management of Anticoagulation, a Randomised Trial [ISRCTN19313375] BMC Family Practice |
author_facet |
Murray Ellen T Fitzmaurice David A McCahon Deborah Fuller Christopher J Hobbs Richard FD Allan Teresa F Raftery James P |
author_sort |
Murray Ellen T |
title |
SMART: Self-Management of Anticoagulation, a Randomised Trial [ISRCTN19313375] |
title_short |
SMART: Self-Management of Anticoagulation, a Randomised Trial [ISRCTN19313375] |
title_full |
SMART: Self-Management of Anticoagulation, a Randomised Trial [ISRCTN19313375] |
title_fullStr |
SMART: Self-Management of Anticoagulation, a Randomised Trial [ISRCTN19313375] |
title_full_unstemmed |
SMART: Self-Management of Anticoagulation, a Randomised Trial [ISRCTN19313375] |
title_sort |
smart: self-management of anticoagulation, a randomised trial [isrctn19313375] |
publisher |
BMC |
series |
BMC Family Practice |
issn |
1471-2296 |
publishDate |
2003-09-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Oral anticoagulation monitoring has traditionally taken place in secondary care because of the need for a laboratory blood test, the international normalised ratio (INR). The development of reliable near patient testing (NPT) systems for INR estimation has facilitated devolution of testing to primary care. Patient self-management is a logical progression from the primary care model. This study will be the first to randomise non-selected patients in primary care, to either self-management or standard care.</p> <p>Method</p> <p>The study was a multi-centred randomised controlled trial with patients from 49 general practices recruited. Those suitable for inclusion were aged 18 or over, with a long term indication for oral anticoagulation, who had taken warfarin for at least six months. Patients randomised to the intervention arm attended at least two training sessions which were practice-based, 1 week apart. Each patient was assessed on their capability to undertake self management. If considered capable, they were given a near patient INR testing monitor, test strips and quality control material for home testing. Patients managed their own anticoagulation for a period of 12 months and performed their INR test every 2 weeks. Control patients continued with their pre-study care either attending hospital or practice based anticoagulant clinics.</p> <p>Discussion</p> <p>The methodology used in this trial will overcome concerns from previous trials of selection bias and relevance to the UK health service. The study will give a clearer understanding of the benefits of self-management in terms of clinical and cost effectiveness and patient preference.</p> |
url |
http://www.biomedcentral.com/1471-2296/4/11 |
work_keys_str_mv |
AT murrayellent smartselfmanagementofanticoagulationarandomisedtrialisrctn19313375 AT fitzmauricedavida smartselfmanagementofanticoagulationarandomisedtrialisrctn19313375 AT mccahondeborah smartselfmanagementofanticoagulationarandomisedtrialisrctn19313375 AT fullerchristopherj smartselfmanagementofanticoagulationarandomisedtrialisrctn19313375 AT hobbsrichardfd smartselfmanagementofanticoagulationarandomisedtrialisrctn19313375 AT allanteresaf smartselfmanagementofanticoagulationarandomisedtrialisrctn19313375 AT rafteryjamesp smartselfmanagementofanticoagulationarandomisedtrialisrctn19313375 |
_version_ |
1724647891552698368 |